U.S. DOT Considers Testing Truck Drivers, Train Operators for Sleep Apnea

In an attempt to reduce the risk of accidents that kill or injury thousands each year, government transportation officials are considering new requirements that all rail workers and commercial vehicle operators undergo sleep apnea screening. 

The U.S. Department of Transportation (DOT) released an Advance Notice of Proposed Rulemaking (ANPRM) on March 8, 2016, seeking the public’s input over the next 90 days about whether it should test truck drivers, train operators and others for obstructive sleep apnea (OSA), which may cause individuals to suffer interrupted sleep patterns or otherwise impair their ability to remain focused and immediately responsive at all times.

There will be three public sessions across the U.S.to gather additional medical advice and public opinion on the risks associated with sleep apnea among commercial drivers.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

In conjunction with the Federal Railroad Administration (FRA) and the Federal Motor Carrier Safety Administration (FMCSA), the U.S. DOT announced the proposed rulemaking in the first ever attempt to require testing of sleep apnea specifically. The proposed regulation was encouraged by the National Transportation Safety Board (NTSB), which estimates that more than 22 million men and women in the U.S. may suffer from undiagnosed obstructive sleep apnea..

Obstructive sleep apnea is a disorder in which an individual’s breathing repeatedly stops and starts during sleep from the throat muscles intermittently relaxing and blocking the airway.

When the airway is blocked while sleeping, this causes inadequate breathing which may lead to insufficient oxygen levels in the blood. Often individuals with sleep apnea have constant interrupted sleep patterns because the brain briefly sends a distress signal wakening the individual,. However, these interruptions are usually not long enough to be remembered.

Sleep apnea episodes that block normal breathing patterns have been recorded to occur on average up to thirty times per hour. Persistently poor sleep patterns due to sleep apnea prevent sufferers from reaching the required sleep phases for individuals to remain attentive for long periods of time the next day.

Side effects of sleep apnea often cause unintended sleep episodes and deficits in attention, concentration, situational awareness, memory, and can reduce capacity to safely respond to hazards.

Studies have also shown that men who suffer from sleep apnea are at a greater risk of coronary artery disease, heart attack, heart failure and strokes.

According to the American Academy of Sleep Medicine, an eight hour night of sleep for an individual with sleep apnea can actually be less refreshing than four hours of ordinary and uninterrupted sleep.

“It is imperative for everyone’s safety that commercial motor vehicle drivers and train operators be fully focused and immediately responsive at all times,” U.S. Transportation Secretary Anthony Foxx said in a press release. “DOT strongly encourages comment from the public on how to best respond to this national health and transportation safety issue.”

Data from the FMCSA indicates that between 2011 and 2012 alone, fatal accidents involving large trucks has increased five percent, causing nearly 4,000 deaths per year. Accidents involving large trucks resulting in injuries increased by 22% during the same time frame.

Current rules state that any commercial motor vehicle driver who is detected to have a respiratory dysfunction such as sleep apnea undergo further evaluation and therapy by a medical professional. According to the DOT, the proposed rule would set mandatory screening for all drivers rather than relying on suspicion.

The FRA and FMCSA will be hosting three public listening sessions to gather information and opinion on the ANPRM in Washington, D.C., Chicago and Los Angeles. Over the next 90 days the public is encouraged to give their input on the impacts of screening, evaluating, and treating rail workers and commercial driver for OSA.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.